Series B · Biotech
Mirador Therapeutics: Series B
Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases
Funding history
Series B · This round$250M
Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases